- Home
- ECOR vs RGS Comparison
ECOR vs RGS Comparison
Compare ECOR & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- RGS
- Stock Information
- Founded
- ECOR 2005
- RGS 1922
- Country
- ECOR United States
- RGS United States
- Employees
- ECOR N/A
- RGS N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RGS Other Consumer Services
- Sector
- ECOR Health Care
- RGS Consumer Discretionary
- Exchange
- ECOR Nasdaq
- RGS Nasdaq
- Market Cap
- ECOR 39.7M
- RGS 47.4M
- IPO Year
- ECOR 2018
- RGS 1991
- Fundamental
- Price
- ECOR $5.37
- RGS $19.26
- Analyst Decision
- ECOR Strong Buy
- RGS
- Analyst Count
- ECOR 2
- RGS 0
- Target Price
- ECOR $25.50
- RGS N/A
- AVG Volume (30 Days)
- ECOR 118.5K
- RGS 10.5K
- Earning Date
- ECOR 08-06-2025
- RGS 08-27-2025
- Dividend Yield
- ECOR N/A
- RGS N/A
- EPS Growth
- ECOR N/A
- RGS N/A
- EPS
- ECOR N/A
- RGS 41.20
- Revenue
- ECOR $27,700,000.00
- RGS $199,112,000.00
- Revenue This Year
- ECOR $23.21
- RGS N/A
- Revenue Next Year
- ECOR $44.10
- RGS N/A
- P/E Ratio
- ECOR N/A
- RGS $0.52
- Revenue Growth
- ECOR 30.16
- RGS N/A
- 52 Week Low
- ECOR $4.16
- RGS $15.00
- 52 Week High
- ECOR $19.49
- RGS $29.28
- Technical
- Relative Strength Index (RSI)
- ECOR 42.75
- RGS 39.61
- Support Level
- ECOR $4.16
- RGS $19.16
- Resistance Level
- ECOR $5.74
- RGS $19.77
- Average True Range (ATR)
- ECOR 0.53
- RGS 0.63
- MACD
- ECOR -0.16
- RGS 0.06
- Stochastic Oscillator
- ECOR 37.19
- RGS 59.22
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.